Market Overview
Iowa cannabis industry snapshot · March 2026
CBD oil only; highly restricted
Licensed cultivators
Excise on retail sales
N/A
Annual Production Volume
Licensed cultivation output estimates 2020-2025
Revenue Trend
Sales by Product Category
Retail sales breakdown — all licensed channels
2025 Sales by Category
Category Revenue ($M)
| Category | Share | Est. Sales ($M) | Trend |
|---|---|---|---|
| 🌸 Flower | 0% | $0M | Stable |
| 🍬 Edibles | 60% | $25M | Growing |
| 💧 Concentrates | 5% | $2M | Strong growth |
| 🧴 Other | 35% | $14M | Stable |
Revenue Statistics
Annual revenue, growth rates, and tax contribution
Annual Revenue 2020-2025 ($M)
Estimated annual cannabis revenue — all licensed channels
| Year | Revenue ($M) | YoY Change | Est. Tax Rev. | Status |
|---|---|---|---|---|
| 2020 | $22M | — | N/A | CBD Medical |
| 2021 | $25M | +13.6% | N/A | CBD Medical |
| 2022 | $28M | +12.0% | N/A | CBD Medical |
| 2023 | $32M | +14.3% | N/A | CBD Medical |
| 2024 | $38M | +18.8% | N/A | CBD Medical |
| 2025 | $42M | +10.5% | N/A | CBD Medical |
Iowa Cannabis — 2025 Market Summary
Iowa's cannabis market reached an estimated $42M in 2025 under CBD Medical regulation. With 0% state excise and 3K lbs of licensed production, the market is maturing steadily. Federal policy changes in 2025 are expected to further catalyse investment and market expansion.
Influential Factors
Legislative, market, and operational drivers
📋 Legal Framework
Iowa operates under CBD Medical law. CBD oil only; highly restricted
📈 Revenue Trajectory
Market grew from $22M (2020) to $42M (2025) — steady growth.
🏪 Retail Landscape
Licensed dispensaries expand access as consumer demand matures. Competition is intensifying, driving promotional pricing and differentiation.
💸 Tax Policy
The 0% state excise keeps pricing competitive. Tax proceeds fund public health, education, and social equity programmes.
🌱 Cultivation
Licensed cultivators produce approximately 3K lbs annually across indoor, greenhouse, and outdoor operations.
🔮 2025-2026 Outlook
Federal rescheduling to Schedule III could reshape banking, taxes, and research access. Price compression in flower continues while concentrates and edibles gain share.
Legislative Timeline
Key milestones 2012-2025
Adult-use cannabis commerce becomes legal in two states, establishing the US regulatory blueprint.
Industrial hemp (<0.3% THC) legalised nationally, spawning the CBD consumer market.
Cannabis declared 'essential' in many states; dispensary sales surge during pandemic lockdowns.
State legislative and regulatory developments shaped Iowa's current CBD Medical framework.
Cannabis moved to Schedule III — potential transformation of banking access and tax treatment.
⚠️ Data Disclaimer
- All figures are estimates from government agencies, industry associations, and academic research.
- Cannabis markets are rapidly evolving; data reflects estimates as of March 2026.
- Some figures are projections or modelled estimates where official data is unavailable.
- CannBus accepts no liability for decisions made based on information on this page.
📚 References & Sources
- USDA / State Revenue Departments — Annual Cannabis Tax Reports
- MJBizDaily — State-by-State Cannabis Market Data 2020–2025
- BDSA Cannabis Market Intelligence — Retail Sales Reports
- Health Canada — Cannabis Market Data Reports
- COFEPRIS / CONASAMES — Mexico Medical Cannabis Framework
- UNODC — World Drug Report 2024
- New Frontier Data — Cannabis Industry Annual Report 2025
- Whitney Economics — US Cannabis Industry Report 2025
- Statista Cannabis Market — Global & Regional Data 2024
- CannBus Market Reports · www.cannbus.org · March 2026